申请人:Pellficure Pharmaceuticals, Inc.
公开号:US10093620B2
公开(公告)日:2018-10-09
Disclosed herein are 1,4-naphthoquinone analogs, pharmaceutical compositions that include one or more of such 1,4-naphthoquinone analogs, and methods of treating and/or ameliorating diseases and/or conditions associated with a cancer, such as prostate cancer with such 1,4-naphthoquinone analogs. Also included are combination therapies wherein a 1,4-naphthoquinone analog disclosed herein, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.
本文公开了1,4-萘醌类似物、包括一种或多种此类1,4-萘醌类似物的药物组合物,以及用此类1,4-萘醌类似物治疗和/或改善与癌症(如前列腺癌)相关的疾病和/或病症的方法。还包括组合疗法,其中向患有癌症等疾病的受试者提供本文公开的 1,4-萘醌类似物和激素治疗剂。